Loading organizations...
§ Private Profile · Baltimore, MD, USA
Immuno-Oncology company developing novel cancer therapies.
VerImmune has raised $10.1M across 3 funding rounds.
VerImmune has raised $10.1M in total across 3 funding rounds.
VerImmune has raised $10.1M across 3 funding rounds. Most recently, it raised $4.5M Pre-Series A in September 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 24, 2024 | $4.5M Seed Plus | Beiley Biofund | — | Announced |
| Sep 20, 2023 | $3.1M Seed | — | — | Announced |
| Jul 29, 2022 | $2.5M Seed | Seedfolio | — | Announced |
VerImmune has raised $10.1M in total across 3 funding rounds.
VerImmune's investors include Beiley Biofund, SeedFolio.